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Abstract
Background: Musculoskeletal pain syndrome (MPS) is one of the modern diseases. Musculoskeletal pain (MP) may
develop at any age and impact physical and mental health. This study aimed to evaluate the association between
anxiety, depression, and insomnia with musculoskeletal pain source. This cross-sectional study was conducted on
450 patients with musculoskeletal pain. Goldberg depression (GB), Beck Anxiety Inventory (BAI), and Morin Insomnia
Severity Index (ISI) questionnaires were used to collect data. Participants have divided into two groups: individuals
with unknown musculoskeletal pain sources and individuals with known musculoskeletal pain sources. Anxiety,
depression, and insomnia scores were compared between the two groups. For statistical analysis of data mean (SD),
frequency (%), Chi-square, Mann-Whitney test, and Logistic regression models were used. All analysis was
performed using SPSS 26.
Results: In this study, 39.4% of the participants were in severe depression, 31.1% in severe anxiety, 34.7% in the no
clinically significant, and 32.9% in the sub-threshold insomnia group. There was a significant difference between the
severity of anxiety and insomnia in the two groups with the known and unknown pain sources (p < 0.05). However,
the score of depression (OR = 1.00, 95% CI 0.99–1.01), anxiety (OR = 1.00, 95% CI 0.99–1.02), and insomnia (OR =
1.01, 95% CI 0.98–1.03) was not related to the pain source.
Conclusion: There was a statistically significant relationship between anxiety and insomnia severity with
musculoskeletal pain source. According to the high prevalence of depression, anxiety, and depression in both
groups with known and unknown musculoskeletal pain sources, the cooperation of orthopedists, rheumatologists,
and physical therapists with psychiatrist can be useful in improving the condition of patients.
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Background
Musculoskeletal pain syndrome (MSPs) is one of the
most common disorders of modern and developing
countries, which may cause dysfunction and disability.
MSPs are one of the most common disorders of modern
and developing countries, which may cause dysfunction
and disability [1]. This syndrome majorly consists of a
wide range of degenerative inflammatory conditions, af-
fecting the muscles, tendons, ligaments, joints, periph-
eral nerves, and supporting blood vessels [1]. The
musculoskeletal pain (MP) is a wide-spread problem,
which accounts for the third part of all acute and
chronic pain syndromes [2]. The MP may have a known
or unknown source. The prevalence of MP with an un-
known source in the community is 15 to 30%. It includes
musculoskeletal pains that there is no structural or in-
flammatory cause for them after careful evaluation [3].
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MP may develop at any age and result in considerable
limitations in a motor activity and a remarkable decrease
in the quality of life. Thus, MSP remains a pressing
medical and social problem [2]. MP impacts on physical
and mental health [4]. The link between chronic pain
and mental health has been recognized for a long time
[5]. Their association can acknowledge at a biological,
psychological, and social level, as they thought to share
common neural mechanisms interact in their develop-
ment over time and have a bidirectional relationship
with environmental factors (e.g., social support, work-
related factors) [6, 7].
Psycho-social factors such as emotional and behavioral
disorders have also been reported to be associated with
MP [8, 9]. The mechanisms underlying the association
appear to be complex and multi-factorial [4]. Negative
affect, anxiety, and depression are associated with lower
pain thresholds in healthy individuals and exacerbated in
chronic pain states, including musculoskeletal disorders
[10, 11]. Negative affect is major cause of disability and
chronic musculoskeletal pain [12].
Pain and depressive disorders often present together.
About half of pain patients fulfill the criteria for depres-
sion [13]. When depression and pain co-occur, both dis-
orders can have an additive adverse effect on health and
its management. The pain can increase the complexity
in the treatment of depression and interferes with recov-
ery, while depression has a similar impact on the thera-
peutic response for the pain [14]. Anxiety or depression
seems to be associated with the development and main-
tenance of chronic musculoskeletal pain. They can also
harm the outcomes of surgery or rehabilitation programs
[5].
Musculoskeletal pain and insomnia have a reciprocal
relationship. Each of these conditions increases the risk
of the other, which may augment the burden on health
and well-being [15]. Musculoskeletal pain may result in
sleep disruption. Pain can induce micro-arousal and in-
crease wakefulness [4]. Insomnia frequently occurs in
patients with chronic pain. The prevalence of this co-
occurrence ranges between 50% and 88% [16]. This
study aimed to evaluate the association between anxiety,
depression, and insomnia with musculoskeletal pain
source (unknown pain source versus known pain source)
in patients referred to orthopedic, rheumatology, and
physical medicine clinics in Shahrekord.
Methods
This cross-sectional study includes patients with pain re-
ferred to Shahrekord orthopedic, rheumatology, and
physical medicine clinics during 2019. In total, 450 pa-
tients (150 cases from each clinic) recruited using a non-
probability sampling method. The sample size was calcu-
lated before the start of the study. With considered
prevalence of mental health factors 50%, confidence level
(95%) = 0.05 and maximum error (d) = 0.05, the samples
size required was 385. 15% of this sample size was added
to it due to increased precision. In total, the minimum
sample size required was 443. Before the assessment, all
patients gave written their informed consent. Patients
filled questionnaires anonymously. Inclusion criteria
Table 2 Comparison of depression, anxiety, and insomnia severity with the pain source
Variables Unknown musculoskeletal pain source (n = 286) Known musculoskeletal pain source (n = 168) P
value*N (%) Mean (SD) N (%) Mean (SD)
Depression No 25 (8.7) 39.99 ± 22.00 16 (9.8) 42.75 ± 25.08 0.116
Mild 30 (10.5) 23 (14.0)
Borderline 19 (6.6) 6 (3.7)
Mild-moderate 62 (21.7) 32 (19.5)
Moderate-severe 59 (20.6) 21 (12.8)
Severe 91 (31.8) 66 (40.2)
Anxiety No 58 (20.2) 19.02 ± 12.98 31 (18.9) 20.87 ± 14.31 0.028
Mild 60 (21.0) 42 (25.6)
Moderate 88 (30.8) 31 (18.9)
Severe 80 (28.0) 60 (36.6)
Insomnia No clinically 103 (36.0) 11.19 ± 6.94 53 (32.3) 11.75 ± 7.52 0.002
Sub threshold 87 (30.4) 61 (37.2)
Moderate severity 75 (26.2) 24 (14.6)
Severe 21 (7.3) 25 (15.2)
*Pearson chi-square
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were age over 20 years, musculoskeletal pain, and con-
sent to participate in the study.
Goldberg’s depression scale (GB), Beck Anxiety Inven-
tory (BAI), and Morin Insomnia Severity Index (ISI)
were used to collect data. The validity and reliability of
all questionnaires have already been confirmed in Iran
[17, 18]. The Cronbach’s alpha of the GB, BAI, and ISI
questionnaires in this study was 0.91, 0.93, and 0.92, re-
spectively. Demographic variables were included age,
gender (male, female), job, have personal Internet, finan-
cial situation, and home type of the participants.
The GD questionnaire has 18 items which are assessed
on a 6-grade Likert scale (very much = 5, quite a lot = 4,
moderately = 3, somewhat = 2, just a little = 1, not at all
= 0). The total score of the questionnaire ranges from 0
to 90, the range 0–9 shows no depression likely, 10–17
shows possibly mildly depressed, 18–21 shows border-
line depression, 22–35 shows mild-moderate depression,
36–53 shows moderate-severe depression, and 54 and
up shows severely depressed. The more total scores are,
the higher depression level will be [18].
The BAI is a self-report measure of anxiety with 21
items. The Likert scale is “Not at all = 0,” “Mildly, but it
didn’t bother me much = 1,” “Moderately – it wasn’t
pleasant at times = 2,” and “Severely – it bothered me a
lot = 3.” The total score is calculated by finding the sum
of the 21 items. Scores range from 0 to 63; higher scores
reflect greater levels of anxiety. A score of 0–7
Table 3 Univariable and multivariable logistic regression results about the association between demographic and mental health
variables with the pain source
Variables Pain source
Univariable Multivariable
OR (95% CI) p value AOR (95% CI) p value
Gender
Male 0.543 (0.367, 0.804) 0.002 0.524 (0.320, 0.858) 0.010
Female 1 1 1 1
Having car
Yes 0.939 (0.639, 1.380) 0.750 – –
No 1 1 – –
Home
Private 0.831 (0.566, 1.221) 0.346 – –
Rental 1 1 – –
Having personal Internet
Yes 0.959 (0.652, 1.411) 0.833 – –
No 1 1 – –
Income (million toman)
1–3 0.838 (0.560, 1.253) 0.389 0.958 (0.608, 1.511) 0.855
> 3 0.597 (0.290, 1.228) 0.161 0.719 (0.324, 1.594) 0.417
< 1 1 1 1 1
Job
Farmer 1.018 (0.530, 1.955) 0.958 1.430 (0.674, 3.030) 0.351
Freelance job 0.889 (0.448, 1.763) 0.736 1.205 (0.562, 2.583) 0.632
Employee 1.059 (0.392, 1.016) 0.852 1.546 (0.778, 3.072) 0.214
Others 0.750 (0.427, 1.317) 0.317 1.069 (0.556, 2.054) 0.842
Manual worker 0.250 (0.100, 0.623) 0.003 0.427 (0.157, 1.160) 0.095
Unemployed/housewife 1 1 1 1
Age 0.977 (0.964, 0.990) < 0.001 0.978 (0.964, 0.992) 0.003
Depression 1.005 (0.997, 1.014) 0.225 – –
Anxiety 1.010 (0.996, 1.025) 0.163 1.007 (0.992, 1.022) 0.373
Insomnia 1.011 (0.984, 1.038) 0.429 – –
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represents no anxiety, 8–15 mild, 16–25 moderate, and
a score of 36 and above represents potentially concern-
ing levels of anxiety [19].
The ISI consists of 25 items, which are evaluated on a
five-point Likert scale ranging from 0 to 4. The mini-
mum and maximum scores of this questionnaire are 0
and 28, and a higher score indicates a serious risk and
need for clinical support. Patient with a score of 0–7
was regarded as no clinically significant insomnia, 8–14
as sub-threshold insomnia, 15–21 as clinical insomnia
(moderate severity), and 22–28 as clinical insomnia (se-
vere) [17, 20].
After collecting data, patients were divided into two
groups: individuals with unknown musculoskeletal pain
sources and individuals with known musculoskeletal
pain sources. Anxiety, depression, and insomnia scores
were compared between the two groups. For this, we
used the Mann-Whitney test because the data distribu-
tion was not normal. Logistic regression models were
used to determine the demographic variables and mental
health factors that were related to pain source. All inde-
pendent variables were entered into the univariable
model and variables with a p value less than 0.2 were en-
tered into the multivariable model. Odds ratio (OR), ad-
justed odds ratio (AOR), and 95% confidence intervals
(95% CI) were reported. P values of < .05 were consid-
ered statistically significant. All analysis was conducted
with SPSS 26.
Ethical approval for this study was obtained from the
Shahrekord University of Medical Sciences. The ethical
code IR.SKUMS.REC.1397.232 was assigned to this study.
Results
In this study, most participants were female (52.7%),
were unemployed or housewife (41.1%), had no car
(52.7%), had income less than one million toman
(47.9%), had a rental house (51.5%), and had no personal
Internet (54.2%). The mean (±SD) age of participants
was 41.90 (± 15.49) years. The mean (SD) of depression,
anxiety, and insomnia in participants was 41.00 (±
23.18), 19.69 (± 13.49), and 11.40 (± 7.15), respectively.
Most people were severely depressed (39.4%), and the
rest had no depression (9.1%), mild depression (11.8%),
borderline depression (5.6%), mild-moderate depression
(20.9%), and moderate-severe depression (17.8%). De-
pression was only dependent on the job variable and in-
dependent of other demographic variables (Table 1).
The situation of depression in demographic subgroups is
shown in Table 1. In each clinic, 150 patients were ex-
amined. Fifty-one patients in the physical medicine, 55
in the rheumatology, and 58 in the orthopedic clinic had
MP with an unknown origin. There was no significant
difference between the scores of depression in the two
groups with the known and unknown pain source (OR =
1.00, 95% CI 0.99–1.01) (Table 3). Also, depression se-
verity was not associated with the pain source (p < 0.05)
(Table 2).
In this survey, 31.1% of participants were in the severe
anxiety, 26.4% in the moderate, 22.7% in mild, and
19.8% in the no anxiety group. Anxiety was dependent
on gender and income (p < 0.05) (Table 1). According to
multivariable regression, anxiety scores were not related
to the pain source (OR = 1.00, 95% CI 0.99–1.02) (Table
3). However, anxiety severity was significantly higher in
the unknown pain source group (p < 0.05) (Table 2).
In this study, 34.7% of participants were in the no clin-
ically significant, 32.9% in the subthreshold, 22.00% in
the moderate-severe clinical, and 10.2% in the severe
clinical insomnia group. Insomnia was independent of
all demographic variables except for having a car. In-
somnia in univariable regression was not significantly as-
sociated with pain source (OR = 1.01, 95% CI 0.98–1.03)
and was not included in multivariable regression. How-
ever, insomnia severity was significantly higher in the
unknown pain source group (p < 0.05) (Table 2).
In multivariable regression, demographic variables of
gender (OR = 0.52, 95% CI 0.32–0.85) and age (OR =
0.97, 95% CI 0.96–0.99) were significantly associated
with decrease the known source of pain. Men and older
age were less OR to have an unknown source of pain
than women and younger age, respectively.
Discussion
In the study, most patients were severely depressed, with
severe anxiety and no clinically significant insomnia.
Also, the prevalence of depression, anxiety, and moder-
ate to severe insomnia in both groups of patients with
known and unknown pain origins was approximately
more than two thirds and one third, respectively. De-
pression severity was not associated with the pain
source. But anxiety and insomnia severity was higher in
the unknown pain source group. Younger age and fe-
males were associated with an unknown pain source.
We could not find studies comparing psychological vari-
ables in pain groups of known and unknown origin.
Most studies compared the pain group with healthy
people.
A study in North Carolina showed that depression was
associated with significantly higher odds of reporting
neck-shoulder pain or wrist/hand pain [21]. In a study
conducted during 2015 in Turkey, there was a statisti-
cally positive significant relationship between the degree
of pain and depressive symptoms [22]. In Rio Grande do
Sul, from February to June 2014 in elderly females, the
score of depression symptoms in participants with
chronic musculoskeletal pain was significantly higher as
compared to participants without chronic musculoskel-
etal pain [23]. Another study in Indianapolis from
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December 2005 until June 2007 reported, the “Pain only”
group had the least pain severity, the “Pain, depression,
and anxiety” group had the greatest severity, and the
“Pain and depression” and “Pain and anxiety” groups
had intermediate severity [24]. Another study in Sweden
and Australasia showed that pain catastrophizing and
heightened depressed mood and have an additive and
adverse effect on the impact of pain, relative to either
alone [25]. Depression is linked to pain strongly. There
is little understanding of how this link works or how it
might be utilized in clinical settings. It is not clear
whether one of the symptoms precedes the other. Al-
though, when both pain and depressive symptoms are
present prognosis of the patient is significantly affected
[26]. Linton and Bergbom suggested two likely mecha-
nisms that can help to explain the link between depres-
sion and pain. First, catastrophizing plays a central role
in models of both pain and depression and hence might
form a meaningful association between them. Second,
emotion regulation is necessary for both depression and
pain since both of them can be viewed as significant
emotional stressors [26].
A study in Indianapolis, between December 2005 and
June 2007, reported that the patients with both musculo-
skeletal pain and depression had greater psychosocial
stress and anxiety than those without depression [27].
MP have associated with anxiety in several ways: (a)
muscle tension is included as a part of the diagnostic cri-
teria for generalized anxiety disorder, (b) pain can be a
common symptom and a good indicator of an anxiety
disorder, (c) anxiety is an independent predictor of the
quality of life in patients with chronic MP, (d) anxiety
leads to higher levels of pain chronicity, and (e) fear,
anxiety, and avoidance are related to MP [28].
A study on a sample of Brazilian workers showed that
musculoskeletal symptoms in the last 12 months were
predictors for insomnia [29]. A longitudinal study in the
Netherlands that baseline data collection took place be-
tween 2004 and 2007, with follow-up assessments of 2,
4, and 6 years later, showed insomnia is a risk factor for
developing chronic pain. Depressive symptoms partially
mediate the effect of insomnia with developing chronic
pain [30]. Another study that conducted in the USA be-
tween June 2010 and December 2011 showed that the
prevalence of no clinically significant insomnia, sub-
threshold insomnia, moderate clinical insomnia, and se-
vere clinical insomnia were 5.5%, 21.2%, 39.6%, and
33.7% in the chronic musculoskeletal pain participants
with disability population, respectively. After controlling
for depression, the correlation between pain and insom-
nia was weak that indicated that insomnia is only a mod-
est part of pain and depression constructs [31].
Insomnia can originate from a painful medical condition
but, in times, may evolve into its disorder related to, but
separate from, the precipitating condition [32]. Dysfunc-
tional sleep and sleep habits can become primary factors
that perpetuate and maintain insomnia. Therefore, sleep
disturbance is no longer directly caused by pain intensity
[31]. When this happens, insomnia can evolve from a
secondary symptom of chronic pain to a primary comor-
bid condition with similar characteristics to primary in-
somnia [33].
One of the limitations of this study is the cross-
sectional nature and lack of causal inference and inverse
causality. Another limitation of this study is the use of
non-probability sampling and the inclusion of only vol-
unteers in the study.
Conclusion
There was a statistically significant relationship between
anxiety and insomnia severity with the unknown muscu-
loskeletal pain source. According to the high prevalence
of depression, anxiety, and depression in both groups
with known and unknown musculoskeletal pain sources,
the cooperation of orthopedists, rheumatologists, and
physical therapists with psychiatrist can be useful in im-
proving the condition of patients.
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